Response to taxane chemotherapy as first subsequent therapy after abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Post-hoc analysis of COU-AA-302 Meeting Abstract


Authors: de Bono, J. S.; Smith, M. R.; Saad, F.; Rathkopf, D. E.; Mulders, P. F. A.; Small, E. J.; Shore, N. D.; Fizazi, K.; De Porre, P.; San Kheoh, T.; Li, J. H.; Todd, M. B.; Griffin, T. W.; Ryan, C. J.
Abstract Title: Response to taxane chemotherapy as first subsequent therapy after abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Post-hoc analysis of COU-AA-302
Meeting Title: 2015 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 7 Suppl.
Meeting Dates: 2015 Feb 26-28
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-03-01
Language: English
ACCESSION: WOS:000356886700186
PROVIDER: wos
DOI: 10.1200/jco.2015.33.7_suppl.184
Notes: Meeting Abstract: 184 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dana Elizabeth Rathkopf
    272 Rathkopf